Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 1
1992 1
1993 4
1994 19
1995 8
1996 14
1997 14
1998 26
1999 14
2000 22
2001 30
2002 26
2003 56
2004 39
2005 60
2006 54
2007 85
2008 123
2009 134
2010 155
2011 217
2012 276
2013 298
2014 393
2015 428
2016 430
2017 434
2018 419
2019 388
2020 398
2021 405
2022 336
2023 293
2024 279
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,924 results

Results by year

Filters applied: . Clear all
Page 1
Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice.
Pastor-Navarro B, Rubio-Briones J, Borque-Fernando Á, Esteban LM, Dominguez-Escrig JL, López-Guerrero JA. Pastor-Navarro B, et al. Int J Mol Sci. 2021 Jun 10;22(12):6266. doi: 10.3390/ijms22126266. Int J Mol Sci. 2021. PMID: 34200878 Free PMC article. Review.
Prostate cancer (PCa) is the most commonly diagnosed cancer in men. The diagnosis is currently based on PSA levels, which are associated with overdiagnosis and overtreatment. Moreover, most PCas are localized tumours; hence, many patients with low-/very low-r …
Prostate cancer (PCa) is the most commonly diagnosed cancer in men. The diagnosis is currently based on PSA levels, whi …
Quality of life in active surveillance for early prostate cancer.
Kato T, Sugimoto M. Kato T, et al. Int J Urol. 2020 Apr;27(4):296-306. doi: 10.1111/iju.14202. Epub 2020 Mar 6. Int J Urol. 2020. PMID: 32141110 Review.
To resolve such problems, attention should be paid to active surveillance as a modern treatment option. This study aimed to systematically review the literature about quality of life in prostate cancer patients undergoing active surveillance …
To resolve such problems, attention should be paid to active surveillance as a modern treatment option. This study aimed to sy …
Update and optimization of active surveillance in prostate cancer in 2021.
Rubio-Briones J, Pastor Navarro B, Esteban Escaño LM, Borque Fernando A. Rubio-Briones J, et al. Actas Urol Esp (Engl Ed). 2021 Jan-Feb;45(1):1-7. doi: 10.1016/j.acuro.2020.09.002. Epub 2020 Oct 16. Actas Urol Esp (Engl Ed). 2021. PMID: 33070989 Review. English, Spanish.
INTRODUCTION AND OBJECTIVES: Within the paradigm shift of the last decade in the management of prostate cancer (PCa), perhaps the most relevant event has been the emergence of active surveillance (AS) as a mandatory strategy in low-risk disease. ...CON …
INTRODUCTION AND OBJECTIVES: Within the paradigm shift of the last decade in the management of prostate cancer (PCa), perhaps …
Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach.
Lee CH, Tan TW, Tan CH. Lee CH, et al. Korean J Radiol. 2021 Jul;22(7):1087-1099. doi: 10.3348/kjr.2020.1224. Epub 2021 Apr 1. Korean J Radiol. 2021. PMID: 33856136 Free PMC article. Review.
MRI has become important for the detection of prostate cancer. MRI-guided biopsy is superior to conventional systematic biopsy in patients suspected with prostate cancer. MRI is also increasingly used for monitoring patients with low-risk prostate …
MRI has become important for the detection of prostate cancer. MRI-guided biopsy is superior to conventional systematic biopsy …
Active surveillance of prostate cancer: MRI and beyond.
Girometti R, Giganti F. Girometti R, et al. Eur Radiol. 2024 Oct;34(10):6215-6216. doi: 10.1007/s00330-024-10717-4. Epub 2024 Mar 28. Eur Radiol. 2024. PMID: 38546791 No abstract available.
mpMRI Interpretation in Active Surveillance for Prostate Cancer-An overview of the PRECISE score.
Harder FN, Heming CAM, Haider MA. Harder FN, et al. Abdom Radiol (NY). 2023 Jul;48(7):2449-2455. doi: 10.1007/s00261-023-03912-2. Epub 2023 May 9. Abdom Radiol (NY). 2023. PMID: 37160473 Review.
Active surveillance (AS) is now included in all major guidelines for patients with low-risk PCa and selected patients with intermediate-risk PCa. ...In 2017, the European School of Oncology initiated the Prostate Cancer Radiological Estimation of Chang …
Active surveillance (AS) is now included in all major guidelines for patients with low-risk PCa and selected patients with int …
Evidence-based approach to active surveillance of prostate cancer.
Witherspoon L, Breau RH, Lavallée LT. Witherspoon L, et al. World J Urol. 2020 Mar;38(3):555-562. doi: 10.1007/s00345-019-02662-5. Epub 2019 Feb 6. World J Urol. 2020. PMID: 30726506 Review.
Active surveillance is a good management option for some men with non-metastatic prostate cancer. In this review, we examine the evidence for several topics related to active surveillance. We examine: (1) which patients should be eligible …
Active surveillance is a good management option for some men with non-metastatic prostate cancer. In this review …
Advances in the selection of patients with prostate cancer for active surveillance.
Liu JL, Patel HD, Haney NM, Epstein JI, Partin AW. Liu JL, et al. Nat Rev Urol. 2021 Apr;18(4):197-208. doi: 10.1038/s41585-021-00432-w. Epub 2021 Feb 23. Nat Rev Urol. 2021. PMID: 33623103 Review.
The success of this approach is critically dependent on the accurate selection of patients who are predicted to be at the lowest risk of prostate cancer mortality. The Epstein criteria for clinically insignificant prostate cancer were first published i …
The success of this approach is critically dependent on the accurate selection of patients who are predicted to be at the lowest risk of …
Risk Stratification of Low-risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance.
Ho MD, Ross AE, Eggener SE. Ho MD, et al. J Urol. 2023 Jul;210(1):38-45. doi: 10.1097/JU.0000000000003454. Epub 2023 Apr 12. J Urol. 2023. PMID: 37042807 Review.
PURPOSE: While active surveillance is the preferred management for most men with low-risk prostate cancer, a subset may harbor more aggressive disease. ...CONCLUSIONS: Long-term prognosis for men diagnosed with low-risk prostate cancer is …
PURPOSE: While active surveillance is the preferred management for most men with low-risk prostate cancer, a sub …
Management of intermediate-risk prostate cancer with active surveillance: never or sometimes?
Masic S, Washington SL 3rd, Carroll PR. Masic S, et al. Curr Opin Urol. 2017 May;27(3):231-237. doi: 10.1097/MOU.0000000000000387. Curr Opin Urol. 2017. PMID: 28234748 Review.
PURPOSE OF REVIEW: Active surveillance has become the recommended management strategy for most patients with low-risk prostate cancer (PCa), but whether surveillance criteria can be expanded without compromising oncologic outcomes is a matter of …
PURPOSE OF REVIEW: Active surveillance has become the recommended management strategy for most patients with low-risk prost …
4,924 results